OVERVIEW
Meningiomas and gliomas pose significant challenges in neuro-oncology due to their complexity and diversity. This masterclass convenes experts to explore cutting-edge diagnostic and therapeutic innovations transforming their management. Advanced imaging and molecular classifications improve diagnostic accuracy, while novel systemic therapies, radiotherapy techniques, and surgical strategies expand treatment options. Special lectures highlight pioneering approaches, including neurosurgical integration with oncology, immunotherapy for high-grade gliomas, and technological enhancements in glioblastoma care. Innovations in supportive care also prioritize patient quality of life. Targeting specialists, this event aims to advance clinical practice and elevate patient outcomes.
SCIENTIFIC COORDINATORS
Dott. Giuseppe Lombardi, Dirigente Medico UOC Oncologia 1, Istituto Oncologico Veneto, IRCCS, Padova, UOS Neuro-Oncology, Oncology 1, IOV-IRCCS, Padova
Prof. Luca Denaro, Prof. Ordinario Neurochirurgia Università di Padova, Direttore UOC Neurochirurgia Pediatrica e Funzionale AOU Padova
Prof. Marco Krengli, Direttore UOC Radioterapia, IOV-IRCCS Padova, Prof. Ordinario Radioterapia Università di Padova, Presidente AIRO Padova, Presidente AIRO
Prof. Maurizio Corbetta, Prof. Ordinario di Neurologia, Direttore UOC Clinica Neurologica Azienda Ospedale Università di Padova
Dott. Franco Chioffi, Direttore UO Neurochirurgia Azienda Ospedaliera di Padova
CME CREDITS
CME accreditation (valid for Italian participants only) for: Medical Doctor, Nurses, Biologists, Pharmacist, Physical Therapists, Psychologist, Biomedical Laboratory Health Technicians, Medical Radiology Health Technicians.
CME credits: 7 Italian CME credits will be granted to those participants who attend at least 90% of scientific works, fill in the questionnaire assessment of perceived quality and duly fill in the evaluation questionnaires answering correctly 75% of the questions
CONGRESS VENUE
Auditorium San Gaetano, Via Altinate 71 Padova
WITH THE UNCONDITIONAL SPONSORSHIP OF
